Texas Oncology - West Texas — Amarillo, Texas

Texas Oncology - West Texas is a clinical research site located in Amarillo, Texas, United States 79124.

Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

Texas Oncology - West Texas has participated in 8 clinical trials with 6 currently active.

Therapeutic areas: HER2-positive Breast Cancer, Cancer, Recurrent or Metastatic Solid Tumors.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer, Harbinger Health, Daiichi Sankyo.

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Texas Oncology - West Texas?

Texas Oncology - West Texas has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Texas Oncology - West Texas conducted?

Texas Oncology - West Texas has 8 clinical trials on record, with 6 currently active. Their work covers HER2-positive Breast Cancer, Cancer, Recurrent or Metastatic Solid Tumors.

Is Texas Oncology - West Texas accredited by Crixeo Health?

Yes — Texas Oncology - West Texas holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Texas Oncology - West Texas?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.